Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs

Go back to Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs
TONIX PHARM HLDG (NASDAQ: TNXP) Delayed: 11.96 -0.24 (1.97%)
Previous Close $12.20    52 Week High $7.95 
Open $11.79    52 Week Low $0.40 
Day High $12.58    P/E N/A 
Day Low $11.78    EPS $-5.33 
Volume 466,811